"Government of India has signed an agreement with the International Development Association (IDA) to support components under the Revised National Tuberculosis Control Programme (RNTCP) for USD 100 million for the period between April 2014 and April 2017 for procurement of drugs, diagnostics and services.
"The sanctioned funds have been spent only on recommended activities and as per norms. The booked expenditure up to March 2016 is 14.42 million USD," Health Minister Jagat Prasad Nadda said in a reply in Rajya Sabha amid noisy scenes in the House over the Uttarakhand issue.
He said this restructuring has been approved by the government and World Bank recently and under the hybrid model and the claims of reimbursement of another USD 22 million have been processed.
Replying to a question about the impact of the tuberculosis programme and how long will it continue, Nadda said "this continuous programme is running. We have made new interventions. The programme had got a big sluggish in between. We have tried to rectify it. Many new interventions have been made and very soon, we will be able to curb tuberculosis."
"We have made a vibrant programme where we have restructured the whole system and the fund is being utilised," he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
